Averin Capital Acquisition
ACAAU · NASDAQ
About ACAAU
- Employees
- 0
- Headquarters
- New York City, New York
- Listed
- Feb 19, 2026
- Sector
- N/A
- Industry
- N/A
ACAAU key statistics
- Market cap
- 357.54M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 182
- Volume
- 2.40K
- Open price
- $10.11
- High today
- $10.11
- Low today
- $10.09
- 52 Week high
- $11.83
- 52 Week low
- $9.95
Averin Capital Acquisition (ACAAU) at a glance
Averin Capital Acquisition (ACAAU) last traded at $10.11, with a market cap of 357.54M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $10.09 and $10.11. The current price is 0.2% above the day's low and 0.0% below its high.
Volume so far is 2.40K shares, above the average of 182 shares a day.
Over the past year Averin Capital Acquisition has ranged from $9.95 to $11.83, and now sits 9% of the way up that range.
Most active stocks
Highest trading volume today
- MERCMercer International$0.212+68.25%
- MASNMaison Luxe$0.0005+233.33%
- HUBCHub Cyber Security$0.1067+30.12%
- SEIISharing Economy International$0.0001−50.00%
- EARIEntertainment Arts Research$0.0002+0.00%
- AXXAExxe Group$0.0005−9.09%
- GRABGrab Holdings$3.12+9.09%
- AEFIAmerican EcoFuels$0.0008−5.88%
- BELRBell Rose Capital$0.0002+0.00%
- NBNDNetBrands$0.0008+25.00%
- INTCIntel$60.55+0.97%
- NVDGraniteShares ETF Trust$4.33−4.63%
Newly listed
Companies that went public in the past six weeks
- NARANarragansett Bancorp$10.91+1.02%
- ASPEAspen Neuroscience$12.29−5.75%
- BBTXBambusa Therapeutics$16.00+0.00%
- GBCGEORGIA BANKING$34.00−8.80%
- BHAIUBHAV Acquisition Corp II$10.01+0.15%
- SCQCUSPACCircle Acquisition$9.99+0.18%
- LYCALycia Therapeutics$27.60+1.55%
- DAVIDAVION HEALTHCARE$1.54+3.36%
- TCXBTCGX Acquisition Corp. II$10.10−0.39%
- CTYCITY THERAPEUTICS$19.09−8.57%
- IAMIambic Therapeutics$13.49+4.13%
- AMROAmaero$5.45−4.72%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.